The CNAT chart settings shown below allow you to select time intervals of 1 min, 30 mins, an hour or by day - week - month. There is also the ability to change the CNAT chart style to candles, hollow candles, bars, lines or add various indicators. You can even add a symbol and compare history.
The CNAT stock resources shown below were gathered to cut back on time by allowing you to visit multiple sites at once. For your convenience each link clicked will open in a window. In addition to the individual links there is a button at the bottom that will allow you to open all the links at the same time. Note opening all links at once may not work with all browsers. Some browsers block multiple windows, to resolve this please allow that site to use pop-ups.
|View CNAT Detailed Price Forecast - CNN Money||View CNAT Detailed Summary - Google Finance|
|View CNAT Detailed Summary - Yahoo! Finance||View CNAT Stock Research & Analysis - Zacks.com|
|View CNAT Trends & Analysis - Trade-Ideas||View CNAT Major Holders - Barrons|
|View CNAT Call Transcripts - NASDAQ||View CNAT Breaking News & Analysis - Seeking Alpha|
|View CNAT Annual Report - CompanySpotlight.com||View CNAT OTC Short Report - OTCShortReport.com|
|View CNAT Fundamentals - TradeKing||View CNAT SEC Filings - Bar Chart|
|View Historical Prices for CNAT - The WSJ||View Performance/Total Return for CNAT - Morningstar|
|View the Analyst Estimates for CNAT - MarketWatch||View the Earnings History for CNAT - CNBC|
|View the CNAT Earnings - StockMarketWatch||View CNAT Buy or Sell Recommendations - MacroAxis|
|View the CNAT Bullish Patterns - American Bulls||View CNAT Short Pain Metrics - ShortPainBot.com|
|View CNAT Stock Mentions - StockTwits||View CNAT Stock Mentions - PennyStockTweets|
|View CNAT Stock Mentions - Twitter||View CNAT Investment Forum News - Investor Hub|
|View CNAT Stock Mentions - Yahoo! Message Board||View CNAT Stock Mentions - Seeking Alpha|
|View Insider Transactions for CNAT - SECform4.com||View Insider Transactions for CNAT - Insider Cow|
|View CNAT Major Holdings Summary - CNBC||View Insider Disclosure for CNAT - OTC Markets|
|View Insider Transactions for CNAT - Yahoo! Finance||View Institutional Holdings for CNAT - NASDAQ|
|View CNAT Stock Insight & Charts - FinViz.com||View CNAT Investment Charts - StockCharts.com|
|View CNAT Stock Overview & Charts - BarChart||View CNAT User Generated Charts - Trading View|
Biotech Stock Roundup: Gilead to Get New CEO, Biogen In-Licenses Candidate
Posted on Wednesday December 12, 2018
A low key week for the biotech sector with focus on regular pipeline updates.
The Daily Biotech Pulse: FDA Nod For Roche, Bristol-Myers Hikes Dividend, 2 Biotechs To Debut
Posted on Friday December 07, 2018
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peak (Biotech stocks hitting 52-week highs on Dec. 6) Gritstone Oncology Inc (NASDAQ: GRTS ) Down In The Dumps ...
Conatus' Emricasan Misses Primary Endpoint in Mid-Stage Study
Posted on Thursday December 06, 2018
Conatus' (CNAT) emricasan fails to meet the primary endpoint in a phase IIb study on compensated NASH cirrhosis patients at high risk of decompensation.
Shares of Conatus Pharmaceuticals plummet over 50% after Phase 2 trial fails to meet primary endpoint
Posted on Thursday December 06, 2018
Shares of Conatus Pharmaceuticals Inc. plummeted 53% Thursday after the company announced its Phase 2 clinical trial of emricasan did not meet its primary endpoint. Patients with liver damage from nonalcoholic fatty liver disease did not show sufficient patient improvement on the drug compared to a placebo. Stifel analysts downgraded the company to hold from buy and lowered their price target to $4 from $10, while analysts at SunTrust Robinson Humphrey lowered their price target to $12 from $20. Friday's selloff puts the biotech's stock on track to suffer its biggest one-day percentage decline since the company went public in July 2013. Shares of Conatus have fallen 53% in the year to date, and the S&P 500 has fallen 0.1%.